(MedPage Today) — The FDA approved three doses — 1.5 mg, 4 mg, and 9 mg — of a new oral semaglutide formulation for diabetes (Ozempic tablets), Novo Nordisk announced.
An ad for Novo Nordisk’s weight loss pill version of semaglutide (Wegovy…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119829
Author :
Publish date : 2026-02-10 20:35:00
Copyright for syndicated content belongs to the linked Source.
